NCT02897232

Brief Summary

This is a minimal risk, anonymous, convenience sample, social behavioral study using qualitative descriptive survey methods. It is to ascertain community member, physician, resident and medical student perspectives regarding Human Papillomavirus (HPV) infection, associated diseases and to identify barriers which prevent these groups from ensuring that males 9-26 receive the three-shot vaccine series to prevent HPV infection. The research is focused on these questions: Do community members understand the ease of transmission of the HPV virus in males 9-26? Do community members, physicians, residents and medical students have knowledge of the associated diseases that may occur with the HPV virus infection in males age 9-26? Do community members, physicians, residents and medical students know the ages in which males should receive the HPV vaccine three-shot series? What barriers prevent community members and physicians, residents and medical students from ensuring that males 9-26 receive the three-shot vaccine series to prevent HPV infection?

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
386

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jul 2016

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2016

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

September 7, 2016

Completed
6 days until next milestone

First Posted

Study publicly available on registry

September 13, 2016

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2017

Completed
3.1 years until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2020

Completed
Last Updated

February 10, 2021

Status Verified

February 1, 2021

Enrollment Period

8 months

First QC Date

September 7, 2016

Last Update Submit

February 8, 2021

Conditions

Keywords

Human Papillomavirus VaccineHPVPatient AcceptancePhysician ComfortMale VaccinationHPV Associated Cancers

Outcome Measures

Primary Outcomes (1)

  • Barriers to HPV Vaccination

    What are the barriers which prevent community members and physicians, residents and medical students from ensuring that males age 9-26 are vaccinated with the HPV three-shot vaccination.

    60 days

Secondary Outcomes (3)

  • Knowledge pertaining to ease of Human Papillomavirus transmission.

    60 days

  • Knowledge of Associated HPV diseases

    60 days

  • Knowledge of age in which males should be vaccinated against HPV.

    60 days

Study Arms (2)

Community Group Survey

Community members coming into the University Health Shreveport Ambulatory Care Facility.

Other: Survey

Physician Group Survey

Physicians affiliated with LSU Health Shreveport School of Medicine

Other: Survey

Interventions

SurveyOTHER

Clinical Faculty and community will be given a survey to define issues preventing HPV Vaccination

Community Group SurveyPhysician Group Survey

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Northern Louisiana community members in the Ambulatory Care Clinics in University Health. Northern Louisiana, Louisiana State University Health, clinical faculty, residents and medical students.

You may qualify if:

  • All visitors to the Pediatric or Internal Medicine University Health Shreveport Clinics willing to complete a survey
  • Those do not wish to participate in the study
  • Those who English is not their first language
  • Clinical Faculty, Resident, and Medical Student Study
  • Clinical Faculty, Resident, and Medical Student Study

You may not qualify if:

  • Any LSU Health Shreveport Clinical Faculty, Resident, and Medical Student which declines to take the survey or do not attempt to complete it.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Louisiana State University Health

Shreveport, Louisiana, 71103, United States

Location

MeSH Terms

Conditions

Papillomavirus InfectionsHealth Behavior

Interventions

Surveys and Questionnaires

Condition Hierarchy (Ancestors)

Sexually Transmitted Diseases, ViralSexually Transmitted DiseasesCommunicable DiseasesInfectionsDNA Virus InfectionsVirus DiseasesTumor Virus InfectionsGenital DiseasesUrogenital DiseasesDisease AttributesPathologic ProcessesPathological Conditions, Signs and SymptomsBehavior

Intervention Hierarchy (Ancestors)

Data CollectionEpidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public Health

Study Officials

  • Julia M Esparza, MLS

    3186754179

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
ECOLOGIC OR COMMUNITY
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Head, User Education and Outreach Services

Study Record Dates

First Submitted

September 7, 2016

First Posted

September 13, 2016

Study Start

July 1, 2016

Primary Completion

March 1, 2017

Study Completion

April 1, 2020

Last Updated

February 10, 2021

Record last verified: 2021-02

Data Sharing

IPD Sharing
Will not share

Only aggregate data will be shared.

Locations